| scholarly article | Q13442814 |
| P2093 | author name string | Masahiro Oka | |
| Suzie Chen | |||
| Seung-Shick Shin | |||
| Jin Namkoong | |||
| Yarí E Marín | |||
| Jeffrey J Martino | |||
| Karine Cohen-Solal | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1279-1286 | |
| P577 | publication date | 2005-11-21 | |
| P1433 | published in | Cellular Signalling | Q1524097 |
| P1476 | title | Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon | |
| P478 | volume | 18 |
| Q33616544 | A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma |
| Q49907440 | A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma |
| Q33605016 | AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). |
| Q55048919 | Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis With Inhibition of Gli-1 in Human Glioblastoma Cells. |
| Q37673339 | Altered glutamine metabolism and therapeutic opportunities for lung cancer |
| Q91254645 | BMP6-induced modulation of the tumor micro-milieu |
| Q49738986 | CKS1 expression in melanocytic nevi and melanoma |
| Q36970648 | Cutaneous melanoma in genetically modified animals |
| Q49502648 | Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness. |
| Q26752479 | Exosomes: The Link between GPCR Activation and Metastatic Potential? |
| Q35216875 | Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice |
| Q33767083 | FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells |
| Q24646052 | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi |
| Q36409682 | Functional effects of GRM1 suppression in human melanoma cells |
| Q37200841 | G-protein-coupled receptors and melanoma |
| Q34645746 | Genetic analysis of the GRM1 gene in human melanoma susceptibility. |
| Q35315503 | Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation |
| Q37121338 | Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications |
| Q39168954 | Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies |
| Q28607232 | Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model |
| Q30570451 | Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells |
| Q34904277 | Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes |
| Q46382784 | Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma |
| Q35122078 | Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer |
| Q37431333 | Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer |
| Q37502074 | Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer |
| Q38741884 | Metabotropic glutamate receptors in cancer |
| Q30448778 | Metabotropic glutamate receptors: from the workbench to the bedside |
| Q33786919 | Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation |
| Q37789680 | Peripheral glutamate signaling in head and neck areas |
| Q36002759 | Protein kinase Cepsilon makes the life and death decision |
| Q48559262 | Protein kinase Cɛ activity regulates mGluR5 surface expression in the rat nucleus accumbens. |
| Q39591407 | Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo. |
| Q41280249 | Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells |
| Q37627169 | Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development. |
| Q38009398 | Specifying protein kinase C functions in melanoma |
| Q42009322 | Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression |
| Q35911227 | The Akt signaling pathway: an emerging therapeutic target in malignant melanoma. |
| Q44060851 | The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells. |
| Q38532696 | The current management of brain metastasis in melanoma: a focus on riluzole |
| Q37731451 | The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells |
| Q64100930 | The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, and |
Search more.